Rapid Medical has announced the promotion of Eitan Havis to international president of the company. Havis will oversee the commercial expansion of the company’s advanced neurovascular technologies to treat haemorrhagic and ischaemic stroke patients in Europe, Asia, and other geographies.
According to a press release, Havis brings 20 years of sales leadership experience for both growth-stage and large medical device companies. He joined Rapid Medical in 2013 as the vice president of Sales and Marketing and, during his tenure, has helped to grow the company from an early-stage start-up to a well-funded commercial operation.
With Havis’ leadership, the company has launched three product franchises, each providing neurointerventionists with greater control over procedural outcomes than previous offerings and gaining adoption in thousands of hospitals, the release adds.
“Eitan has been a crucial leader in growing the company from its infancy,” said Ronen Eckhouse, CEO and co-founder of Rapid. “His leadership and professional expertise will enable us to further develop and expand our international presence.”
“Rapid Medical’s devices provide interventionists with enhanced control inside of the vessel, allowing them to tailor the treatment to each patient,” added Havis. “I am continuously inspired by our talented team as we bring these advanced solutions to physicians across the globe.”